Literature DB >> 17934874

Spectral filters can improve reading and visual search in patients with multiple sclerosis.

B Newman Wright1, A J Wilkins, Y Zoukos.   

Abstract

We investigated the possible benefit for 26 patients with multiple sclerosis of placing Intuitive Overlays (spectral filters) over the page during reading and visual search. Initially all patients were allowed to select an overlay of a colour that reduced perceptual distortion and were tested with and without that overlay. With the coloured overlay, 25/26 patients reported fewer symptoms of visual stress, 50% read at least 20% more quickly and 50% omitted at least 57% fewer targets during visual search. Subsequently, under double-masked conditions 13 randomly-selected patients were given grey overlays,while the remaining 13 gender- and agematched patients were each given an overlay of their individually selected colour. Patients were permitted to use their overlays as and when they wished during the next 2 weeks. The reading and visual search performance of those patients who had received a grey overlay did not change,whereas the performance of those who received an overlay of their selected colour subsequently improved, both when using the overlays and also when not. After testing, the 13 patients who had received a grey overlay returned it prior to subsequent testing. The 13 patients were then each given an overlay of their selected colour and their performance subsequently improved.A large proportion of patients with multiple sclerosis may benefit from the use of spectral overlays.

Entities:  

Mesh:

Year:  2007        PMID: 17934874     DOI: 10.1007/s00415-007-0648-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  The effect of coloured filters on the rate of reading in an adult student population.

Authors:  Bruce J W Evans; Florence Joseph
Journal:  Ophthalmic Physiol Opt       Date:  2002-11       Impact factor: 3.117

2.  Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.

Authors:  Patrick Flanagan; Andrew J Zele
Journal:  Ophthalmic Physiol Opt       Date:  2004-05       Impact factor: 3.117

3.  Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation.

Authors:  M Donatella Caramia; M Giuseppina Palmieri; M Teresa Desiato; Laura Boffa; Pierluigi Galizia; Paolo M Rossini; Diego Centonze; Giorgio Bernardi
Journal:  Clin Neurophysiol       Date:  2004-04       Impact factor: 3.708

4.  Rate of Reading Test: its reliability, and its validity in the assessment of the effects of coloured overlays.

Authors:  A J Wilkins; R J Jeanes; P D Pumfrey; M Laskier
Journal:  Ophthalmic Physiol Opt       Date:  1996-11       Impact factor: 3.117

5.  The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis.

Authors:  Joey R Gee; Joyce Chang; Arthur B Dublin; Nazhiyath Vijayan
Journal:  Headache       Date:  2005-06       Impact factor: 5.887

6.  Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability.

Authors:  H Reddy; S Narayanan; M Woolrich; T Mitsumori; Y Lapierre; D L Arnold; P M Matthews
Journal:  Brain       Date:  2002-12       Impact factor: 13.501

7.  Epilepsy in patients with multiple sclerosis: radiological-clinical correlations.

Authors:  T Moreau; D Sochurkova; M Lemesle; G Madinier; T Billiar; M Giroud; R Dumas
Journal:  Epilepsia       Date:  1998-08       Impact factor: 5.864

8.  Reading disabilities and the effects of colored filters.

Authors:  P D O'Connor; F Sofo; L Kendall; G Olsen
Journal:  J Learn Disabil       Date:  1990-12

9.  A neurological basis for visual discomfort.

Authors:  A Wilkins; I Nimmo-Smith; A Tait; C McManus; S Della Sala; A Tilley; K Arnold; M Barrie; S Scott
Journal:  Brain       Date:  1984-12       Impact factor: 13.501

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  7 in total

1.  Prevention of Visual Stress and Migraine With Precision Spectral Filters.

Authors:  Arnold Wilkins; Jie Huang; Yue Cao
Journal:  Drug Dev Res       Date:  2007       Impact factor: 4.360

2.  Susceptibility to pattern glare following stroke.

Authors:  Ian G Beasley; Leon N Davies
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

3.  Coloured filters enhance the visual perception of social cues in children with autism spectrum disorders.

Authors:  Amanda K Ludlow; Elaine Taylor-Whiffen; Arnold J Wilkins
Journal:  ISRN Neurol       Date:  2012-03-04

4.  A Delphi study to develop practical diagnostic guidelines for visual stress (pattern-related visual stress).

Authors:  Bruce J W Evans; Peter M Allen; Arnold J Wilkins
Journal:  J Optom       Date:  2016-11-24

5.  The pattern glare and visual memory are disrupted in patients with major depressive disorder.

Authors:  Min Wang; Xiongwei Qi; Xiao Yang; Huanhuan Fan; Yikai Dou; Wanjun Guo; Qiang Wang; Eric Chen; Tao Li; Xiaohong Ma
Journal:  BMC Psychiatry       Date:  2022-08-02       Impact factor: 4.144

6.  The missing N1 or jittered P2: Electrophysiological correlates of pattern glare in the time and frequency domain.

Authors:  Austyn J Tempesta; Claire E Miller; Vladimir Litvak; Howard Bowman; Andrew J Schofield
Journal:  Eur J Neurosci       Date:  2021-08-27       Impact factor: 3.698

7.  High level of pattern glare in major depressive disorder.

Authors:  Xiongwei Qi; Huanhuan Fan; Xiao Yang; Yayun Chen; Wei Deng; Wanjun Guo; Qiang Wang; Eric Chen; Tao Li; Xiaohong Ma
Journal:  BMC Psychiatry       Date:  2019-12-21       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.